Huber Financial Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$476K Sell
15,357
-934
-6% -$31.8K 0.18% 65
2019
Q4
$606K Buy
16,291
+1
+0% +$36 0.21% 60
2019
Q3
$555K Sell
16,290
-893
-5% -$32.5K 0.22% 58
2019
Q2
$706K Hold
17,183
0.31% 45
2019
Q1
$692K Buy
17,183
+7,435
+76% +$298K 0.34% 43
2018
Q4
$404K Hold
9,748
0.22% 60
2018
Q3
$408K Buy
9,748
+1
+0% +$38 0.31% 60
2018
Q2
$335K Hold
9,747
0.31% 64
2018
Q1
$328K Buy
+9,747
New +$335K 0.32% 66

Other funds holding PFE

Huber Financial Advisors's PFE Position: Q1 2020 in Review

Huber Financial Advisors reduced its Pfizer (PFE) stake by 5.7% in Q1 2020, selling an estimated $31.8K and leaving 15,357 shares worth $476K. The position accounts for 0.18% of the portfolio, ranked #65.

Huber Financial Advisors first reported a position in PFE in Q1 2018 and has held it in 9 quarters since. The position peaked at $706K in Q2 2019. 2,438 funds tracked by Wall St. Rank hold PFE as of Q1 2020.

  • Huber Financial Advisors held 15,357 shares of Pfizer worth $476K as of Q1 2020.
  • Huber Financial Advisors sold 934 Pfizer shares in Q1 2020, an estimated $31.8K.
  • Pfizer made up 0.18% of Huber Financial Advisors's portfolio in Q1 2020, its #65 holding.
  • Huber Financial Advisors first reported a position in Pfizer in Q1 2018 and has held it in 9 quarters since.
  • Huber Financial Advisors's Pfizer position peaked at $706K in Q2 2019.
  • 2,438 funds tracked by Wall St. Rank held Pfizer as of Q1 2020.

Based on Huber Financial Advisors's 13F filing for Q1 2020, filed 17 Apr 2020.